FEATURED VIDEOS

• Why Programmable Logic-Gated Cell Therapies Matter

  During this segment of Cell & Gene Live, "Building Smarter Cell Therapies with AI and Synthetic Biology," Senti Biosciences' Tim Lu, M.D., Ph.D., and Claire Aldridge, Ph.D., argued that next-wave CGTs must tackle indications where small molecules and biologics struggle by using multi-target, logic-gated designs to combine deep cancer killing with protection of healthy cells

• Unlocking AI's Potential In Cell Therapy Through Robust Data

  In this final segment of Cell & Gene Live, "Building Smarter Cell Therapies with AI and Synthetic Biology," Senti Biosciences' Tim Lu, M.D., Ph.D., and Claire Aldridge, Ph.D., emphasized that high-quality, diverse data infrastructure, spanning successes, failures, metadata, and experimental context, is foundational for AI and synthetic biology to drive CGTs from discovery to clinic.

• Safer, Smarter Cell Therapies With AI

  In this segment of Cell & Gene Live, "Building Smarter Cell Therapies with AI and Synthetic Biology," Claire Aldridge, Ph.D., shared why the most compelling AI and synthetic biology strategies are those built on proprietary, well annotated experimental data that continuously train and validate models.

• AI Meets Cell Therapy Manufacturing

  During this segment of Cell & Gene Live, "Building Smarter Cell Therapies with AI and Synthetic Biology," Senti Biosciences' Tim Lu, M.D., Ph.D., and Claire Aldridge, Ph.D., advised regulators and partners view AI/circuit-engineered cell therapies with healthy skepticism, reassured by evidence of acceleration (not replacement) of wet lab steps with robust validation data.

• AI-Designed Logic Circuits For Smarter Cancer Targeting

  During this segment of Cell & Gene Live, "Building Smarter Cell Therapies with AI and Synthetic Biology," Senti Biosciences' Tim Lu, M.D., Ph.D. described how an AI-guided workflow at Senti optimized paired activating and inhibitory CAR designs to better distinguish cancer from healthy cells, outperforming manual engineering and accelerating lead selection.

• Moving Beyond Gut Feel In Cell Therapy Design With AI And Synthetic Biology

  In this opening segment of Cell & Gene Live, "Building Smarter Cell Therapies with AI and Synthetic Biology," Senti Biosciences' Tim Lu, M.D., Ph.D., and Claire Aldridge, Ph.D. explained that the complexity of cells requires moving beyond single gene intuition to large-scale design–build–test of gene circuits.

• A Machine Learning, Auto-Gating Tool For Cell Analysis

  Examine how supervised auto-gating reduces flow cytometry analysis time by 18x while eliminating operator bias. Understand the elastic image registration approach and implementation requirements.

• Enable Deeper Characterization During CAR Cell Development

  Discover how advanced spectral flow cytometry and imaging technologies enable real-time visualization of cell interactions, seamless cross-instrument standardization, and efficient workflows.

• Advancing Flow Cytometry Through Automated Analysis

  Discover how innovative gating tools and reagent stability strategies have revolutionized cytometry workflows to enable precision, scalability, and compliance for cell therapy applications.

• Real-Time Imaging With New Image Technology

  Experience real-time imaging that reveals cellular structure without slowing your workflow. Learn how new detector technology can support sorting and show internal and external cell characteristics.

• A Solid Foundation For Pushing The Limits Of Spectral Flow

  See how new technologies simplify spectral workflows, enable seamless panel transfer, and deliver deeper biological resolution for high-parameter analysis—making complex experiments more accessible.

• Accelerate Cross Site Collaboration With Simple Assay Transfer

  Collaboration across sites is critical in the journey from development to manufacturing. Watch to discover how to accelerate cross-site collaboration with simple assay transfer.

• Revolutionize Your Sample Preparation With Precision And Speed

  Watch to learn how you can empower your laboratory team and fully automate a wide range of workflows with a revolutionary sample preparation system.

• Ask The Expert: 21 CFR Part 11 Compliance

  Hear from a 21 CFR Part 11 expert with nearly 20 years of experience supporting pharmaceutical, diagnostic, and medical device companies with implementing solutions and systems to ensure compliance.

• Dissecting Cellular Composition Using Single-Cell Multiomics

  Hear from Dr. Fabio Luciani, Professor and Senior Researcher in Systems Immunology at the School of Medical Sciences and the Kirby Institute at UNSW Sydney about his recent research.

• Why Standardizing Flow Cytometry Is The Key To Advancing CGT

  Watch to learn about solutions to address challenges in standardizing flow cytometry and cell analysis solutions that support drug development at every stage.

• Cell Therapy - Pushing The Limit

  Tremendous advances in the development of cell-based therapies now offer the ability to treat patients who previously had no hope. Watch to learn about the possibilities for cell-based therapies.